Work

Abstract P3-05-02: Quantitative ERα measurements in TNBC from the I-SPY 2 TRIAL correlate with HER2-EGFR co-activation and heterodimerization

Year: 2017

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.sabcs16-p3-05-02

Authors: RI Gallagher, C Yau, DM Wolf, T Dong, G Hirst, L Brown-Swigart, ISPY-2 TRIAL Investigators, M Buxton, A DeMichele, L van't Veer, D Yee, M Paoloni, L Esserman, D Berry, J Park, EF Petricoin, JD Wulfkuhle

Institutions: University of Minnesota, George Mason University, University of California, San Francisco, Quantum Leap Healthcare Collaborative, University of California San Francisco Medical Center, Berry Consultants, LLC (United States), University of Pennsylvania

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2594054386

Cites:

Cited by:

Related to: 10